Frier Levitt attorney Dr. Lawrence F. Kobak, DPM, Esq., published an article, “Closure of a Podiatric Practice” in the November/December 2023 issue of Podiatry Management. The article discusses common concerns podiatrists face when closing a... Read More
Employers and unions say the PBMs are favoring costlier drugs over less expensive options and aren’t open about their rebates. Employers and unions are growing increasingly frustrated with rising costs from pharmacy-benefit managers (PBMs) tasked... Read More
Frier Levitt attorneys Martha Rumore and Jesse Dresser published an article, “With DSCSA Compliance Delay, Certain Requirements Still Require Action Now,” in Pharmacy Times. The article discusses the final phase of the 2013 Drug Supply Chain... Read More
Frier Levitt partner Guillermo Beades published an article, “What to do During a Medical Board Investigation” in Physicians Practice, where he discusses the intricacies of a medical board investigation. Professional licensing boards serve an... Read More
Frier Levitt Co-Founding Partner Daniel Frier was featured in a Medscape article titled "Stripped Privileges: An Alarming Precedent for Community Oncologists?" by M. Alexander Otto, PA, MMS. The article highlights a recent lawsuit in Philadelphia... Read More
We are excited to share our latest edition of the Frier Levitt Life Sciences Newsletter, a thorough guide providing vital perspectives on the constantly changing field of pharmacy law. We are committed to keeping you up to date on all the lates... Read More
We are excited to share our latest edition of the Frier Levitt Healthcare Newsletter, a comprehensive resource delivering critical insights into the ever-evolving landscape of healthcare law. We are committed to keeping you informed, and this... Read More
Frier Levitt is pleased to share the latest edition of our Healthcare Newsletter packed with vital updates on the ever-evolving landscape of healthcare law. In this edition, we cover an array of compelling topics, including OIG’s latest... Read More
Frier Levitt is pleased to share the latest edition of our Life Sciences Newsletter. Keeping you informed on current topics impacting pharmacies, drug manufacturers, and plan sponsors. Topics include the impact of PCMA v. Mulready on independent... Read More
In this latest episode of Watch DSN, senior editor Sandra Levy chats with Lucas Morgan, partner in Frier Levitt’s Healthcare and Life Sciences Litigation group about the importance of state boards of pharmacy. Lucas delves into the significance... Read More
